• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道血凝素特异性IgA抗体在预防流感中的功能作用。

Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.

作者信息

Tamura S, Funato H, Hirabayashi Y, Kikuta K, Suzuki Y, Nagamine T, Aizawa C, Nakagawa M, Kurata T

机构信息

Department of Pathology, Kitasato Institute, Tokyo, Japan.

出版信息

Vaccine. 1990 Oct;8(5):479-85. doi: 10.1016/0264-410x(90)90250-p.

DOI:10.1016/0264-410x(90)90250-p
PMID:2251874
Abstract

Intranasal inoculation of haemagglutinin (HA) purified from influenza virus A/PR/8/34 (PR8, H1N1) together with cholera toxin B subunit, into Balb/c mice resulted in complete protection against PR8 infection in parallel with the induction of high levels of HA-specific IgA and IgG antibodies on the respiratory tract. The respiratory tract IgA and IgG were purified from nasal and lung washings of the immunized mice using affinity columns, and their HA-specific activities were measured by enzyme-linked immunosolvent, plaque neutralization and haemagglutination inhibition assays. The purified IgA and IgG had the following properties: (1) They were able to neutralize virus in vitro. (2) The purified IgA included major antibodies directed against PR8 virus and minor antibodies cross-reactive with A/Yamagata/120/86 (H1N1) or A/Fukuoka/C29/85 (H3N2) virus, while the purified IgG included major antibodies to the homotypic virus, minor antibodies to the H1N1 virus and only a trace amount of antibodies to the H3N2 virus. (3) When separated on a Sephacryl column, most of the IgA anti-HA activities occurred in the polymeric fractions of purified IgA, whereas the IgG anti-HA activities occurred in the monomeric fractions. (4) When passively administered to normal mouse respiratory tract before infection, the purified IgA protected against PR8 infection. These results suggest that HA-specific, polymeric IgA antibodies on the respiratory tract by themselves provide not only protection against the homotypic virus but also higher levels of heterotypic immunity than IgG.

摘要

将从甲型流感病毒A/PR/8/34(PR8,H1N1)中纯化的血凝素(HA)与霍乱毒素B亚基经鼻内接种到Balb/c小鼠体内,可诱导呼吸道产生高水平的HA特异性IgA和IgG抗体,同时使小鼠获得对PR8感染的完全保护。使用亲和柱从免疫小鼠的鼻腔和肺灌洗液中纯化呼吸道IgA和IgG,并通过酶联免疫吸附测定、蚀斑中和试验和血凝抑制试验测定其HA特异性活性。纯化的IgA和IgG具有以下特性:(1)它们能够在体外中和病毒。(2)纯化的IgA包含针对PR8病毒的主要抗体以及与A/山形/120/86(H1N1)或A/福冈/C29/85(H3N2)病毒交叉反应的次要抗体,而纯化的IgG包含针对同型病毒的主要抗体、针对H1N1病毒的次要抗体以及仅痕量的针对H3N2病毒的抗体。(3)在Sephacryl柱上分离时,大多数IgA抗HA活性出现在纯化IgA的多聚体部分,而IgG抗HA活性出现在单体部分。(4)在感染前被动给予正常小鼠呼吸道时,纯化的IgA可保护小鼠免受PR8感染。这些结果表明,呼吸道上的HA特异性多聚体IgA抗体自身不仅能提供针对同型病毒的保护,还能提供比IgG更高水平的异型免疫。

相似文献

1
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.呼吸道血凝素特异性IgA抗体在预防流感中的功能作用。
Vaccine. 1990 Oct;8(5):479-85. doi: 10.1016/0264-410x(90)90250-p.
2
Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.通过被动转移针对不同血凝素分子的呼吸道IgA抗体对甲型流感病毒感染的交叉保护作用。
Eur J Immunol. 1991 Jun;21(6):1337-44. doi: 10.1002/eji.1830210602.
3
Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines.用佐剂联合疫苗经鼻免疫的多聚免疫球蛋白受体基因敲除小鼠对流感病毒感染的防护作用。
J Immunol. 2002 Mar 15;168(6):2930-8. doi: 10.4049/jimmunol.168.6.2930.
4
Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit.使用与霍乱毒素B亚基联合的疫苗进行两剂鼻内接种对流感病毒感染的防护作用。
Vaccine. 1989 Aug;7(4):314-20. doi: 10.1016/0264-410x(89)90192-8.
5
Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.流感血凝素疫苗经鼻接种对皮下接种具有更强的交叉保护作用。
Eur J Immunol. 1992 Feb;22(2):477-81. doi: 10.1002/eji.1830220228.
6
Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.IgA与IgG在小鼠呼吸道流感病毒感染控制中的作用。
J Immunol. 2004 Aug 1;173(3):1978-86. doi: 10.4049/jimmunol.173.3.1978.
7
Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.流感血凝素(HA)疫苗联合霍乱毒素B亚单位鼻内接种与口服或胃肠外接种的比较。
Vaccine. 1990 Jun;8(3):243-8. doi: 10.1016/0264-410x(90)90053-o.
8
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.通过鼻内共同给予杆状病毒表面展示的血凝素(HA)和重组霍乱毒素B亚单位(CTB)作为佐剂,对小鼠进行针对H5N1流感病毒攻击的保护性免疫。
Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.
9
The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus.用作为免疫刺激复合物(ISCOMS)、弗氏完全佐剂(FCA)、铝佐剂(ALH)或感染性病毒给予的流感抗原免疫的小鼠中的IgA和IgG亚类反应及保护作用。
Arch Virol. 1992;125(1-4):71-86. doi: 10.1007/BF01309629.
10
Cross-protection against influenza B type virus infection by intranasal inoculation of the HA vaccines combined with cholera toxin B subunit.通过鼻内接种血凝素(HA)疫苗与霍乱毒素B亚单位联合制剂对B型流感病毒感染的交叉保护作用。
Vaccine. 1990 Dec;8(6):595-9. doi: 10.1016/0264-410x(90)90016-f.

引用本文的文献

1
Comprehensive method for producing high-affinity mouse monoclonal antibodies of various isotypes against (4-hydroxy-3-nitrophenyl)acetyl (NP) hapten.生产针对(4-羟基-3-硝基苯基)乙酰基(NP)半抗原的各种亚型的高亲和力小鼠单克隆抗体的综合方法。
Heliyon. 2024 Nov 29;10(23):e40837. doi: 10.1016/j.heliyon.2024.e40837. eCollection 2024 Dec 15.
2
Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals.在血清阴性暴露个体的鼻腔分泌物中检测到 SARS-CoV-2 特异性分泌型 IgA 和中和抗体。
Viruses. 2024 May 27;16(6):852. doi: 10.3390/v16060852.
3
SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染可在上呼吸道诱导强烈的黏膜抗体反应。
iScience. 2024 Feb 10;27(3):109210. doi: 10.1016/j.isci.2024.109210. eCollection 2024 Mar 15.
4
A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination.一种用于鼻内加强流感疫苗接种的局部和全身免疫的双重佐剂系统。
Vaccines (Basel). 2022 Oct 11;10(10):1694. doi: 10.3390/vaccines10101694.
5
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.鼻内接种腺病毒载体 COVID-19 疫苗的耐受性和免疫原性:一项开放性、部分随机、递增剂量的 I 期临床试验。
EBioMedicine. 2022 Nov;85:104298. doi: 10.1016/j.ebiom.2022.104298. Epub 2022 Oct 10.
6
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.鼻腔接种疫苗诱导针对 SARS-CoV-2 变体的交叉保护分泌型 IgA 抗体,降低肺嗜酸性免疫病理学的潜在风险。
Vaccine. 2022 Sep 29;40(41):5892-5903. doi: 10.1016/j.vaccine.2022.08.049. Epub 2022 Aug 26.
7
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals.SARS-CoV-2 疫苗接种可诱导既往感染者产生黏膜抗体应答。
Nat Commun. 2022 Sep 1;13(1):5135. doi: 10.1038/s41467-022-32389-8.
8
mRNA-based therapeutics: powerful and versatile tools to combat diseases.mRNA 疗法:抗击疾病的强大而多功能的工具。
Signal Transduct Target Ther. 2022 May 21;7(1):166. doi: 10.1038/s41392-022-01007-w.
9
Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA.鼻内预刺激诱导局部肺驻留 B 细胞群体分泌保护性黏膜抗病毒 IgA。
Sci Immunol. 2021 Dec 10;6(66):eabj5129. doi: 10.1126/sciimmunol.abj5129.
10
Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses.减毒活流感疫苗引发的免疫反应作为针对流感病毒的普遍保护的相关因素。
Vaccines (Basel). 2021 Apr 7;9(4):353. doi: 10.3390/vaccines9040353.